CARDIOVASCULAR  INNOVATIONS  FOUNDATION

CVI 2020 Digital

July 10, 2020 – July 10, 2021

TARGET AUDIENCE

This activity has been designed to meet the educational needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases.

EDUCATIONAL GOAL

The goal of this activity is to provide participants with knowledge and state-of-the-art management information on how to evaluate and treat patients with coronary artery disease, peripheral vascular disease, and valvular, structural heart and arrhythmic heart disease.

LEARNING OBJECTIVES

  • Identify and assess risk factors leading to procedural complications
  • Describe optimal diagnostic and treatment strategies (including coronary revascularization, medications, and lifestyle interventions) for patients with both chronic coronary artery disease and acute coronary syndromes
  • Discuss the guideline-based indications and best-practice recommendations for the use of hemodynamic support devices, intra-vascular imaging, coronary physiologic, structural heart devices, antiplatelet, lipid-lowering and antithrombotic drug interventions
  • Identify potential complications associated with endovascular treatment of carotid disease, acute and chronic DVT, pulmonary embolism, CTEPH, thoracic and abdominal aortic aneurysms, and CLI
  • Describe state-of-art strategies for obtaining vascular access, overcoming challenges, and preventing and promptly treating access complications

ACCREDITATION

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Cardiovascular Innovations Foundation. The CMEsolutions is accredited by the ACCME to provide continuing medical education for physicians.

The CMEsolutions designates this enduring internet activity for a maximum of 18 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing nursing education activity was approved by the Continuing Nursing Education Group, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. 
This activity is designated for 16 Contact Hours.

Start Date: July 10, 2020        End Date: July 10, 2021

FEES

There is no registration fee for this activity.

PARTICIPATION REQUIREMENTS

  1. Participate in credit designated sessions
  2. For credit login to https://online-med-edu.com/cvi2020/digital (you are here)
  3. Complete the Evaluation/Credit Request Form
  4. Download or Print Credit Statement- No credit requests will be accepted after July 10, 2021

FACULTY AND DISCLOSURES

CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. CMEsolutions has resolved all conflicts of interest prior to this educational activity.

Mazen Abu Fadel, MD, FACC, FSCA
Clinical Professor of Medicine, Oklahoma Heart Hospital North Campus
Oklahoma City, OK
Mazen Abu Fadel has no relevant financial relationship to disclose

Khaldoon Alaswad, MD
Director, Cardiac Catheterization Lab, Henry Ford Hospital
Detroit, MI
Khaldoon Alaswad has no relevant financial relationship to disclose

Chadi Alraies, MD, MPH
Director, Interventional Cardiology Research, Detroit Medical Center
Detroit, MI
Chadi Alraies has disclosed the following relevant financial relationships: Abiomed, Cardiovascular Systems-Consultant

Guilherme Attizzani, MD
Director, Valve and Structural Heart Disease Intervention, University of Cleveland
Cleveland, OH
Guilherme Attizzani has disclosed the following relevant financial relationships: Medtronic-Consultant

Lorenzo Azzalini, MD, PhD, MSc
Director, Complex Coronary Interventions, VCU Health, Pauley Heart Center
Richmond, VA
Lorenzo Azzalini has disclosed the following relevant financial relationships:  Abbott Vascular, Sahajanand Medical Technologies, Terumo Medical-Consultant; Guerbet-Consultant, Research Grant; ACIST Medical-Research Grant

Richard Bae, MD
Director, Echocardiography Laboratory and Interventional Echocardiography, Minneapolis Heart Institute
Minneapolis, MN
Richard Bae has disclosed the following relevant financial relationships:  Abbott Vascular-Speaker Bureau

Sudhash Banerjee, MD
Chief of Cardiology, VA North Texas Health Care System
Dallas, TX
Sudhash Banerjee has disclosed the following relevant financial relationships:  AstraZeneca-Speaker Bureau; Boston Scientific-Institutional Research Grant; Livmore, Inc.-Consultant

Vinayat Bapat, FRCS, CTh
Assistant Professor, Columbia University Medical Center
New York, NY
Vinayat Bapat has disclosed the following relevant financial relationships:  4C, Admedus, Boston Scientific, Medtronic-Consultant

Colin Barker, MD       
Director, Interventional Cardiology, Vanderbilt University Medical Center
Nashville, TN
Colin Barker has disclosed the following relevant financial relationships:  Boston Scientific, Medtronic-Consultant

Emmanouil S. Brilakis, MD, PhD
Director, Center for Complex Coronary Interventions, Minneapolis Heart institute
Minneapolis, MN
Emmanouil Brilakis has disclosed the following relevant financial relationships: Abbott Vascular; Boston Scientific; CSI; GE Healthcare-Consultant, Speaker Bureau; Amgen; Infra Redx; Teleflex-Speaker Bureau; Regeneron; Siemens Healthineers-Research Grant; Speaker Bureau; Elsevier-Consultant

M. Nicholas Burke, MD         
Director CV Lab Operations and Co-Director, Center for Complex Coronary Interventions, Minneapolis Heart Institute
Minneapolis, MN
M. Nicholas Burke has disclosed the following relevant financial relationships:  Egg Medical, MHI Ventures, Opsens-Speaker Bureau

Joao Cavalcante, MD
Director, Cardiac MRI and Structural CT Lab, Minneapolis Heart Institute
Minneapolis, MC
Joao Cavalcante has disclosed the following relevant financial relationships:  Abbot Vascular, Boston Scientific-Consultant; Circle Cardiovascular Imaging-Consultant, Research Grant; Siemens Healthineers-Consultant, Speaker Bureau; Edwards Lifesciences-Research Grant

Adnan K. Chhatriwalla, MD
Medical Director, Structural Intervention, Saint Luke’s Mid-America Heart Institute
Kansas City, MO
Adnan Chhatriwalla has disclosed the following relevant financial relationships:  Abbott Vascular- Speaker Bureau; Boston Scientific-Consultant, Research Grant; Edwards Lifesciences-Proctor, Research Grant; Medtronic-Proctor; Silk Road Medical-Consultant

Mauricio Cohen, MD
Director, Cardiac Catheterization Laboratory, University of Miami Miller School of Medicine
Miami, FL
Mauricio Cohen has disclosed the following relevant financial relationships: Abiomed-Consultant, Speaker Bureau; Accumed Radial Systems, AstraZeneca, Medtronic, Merit Medical, Terumo, Zoll-Consultant

Peter A. Crisologo, DPM, AACFAS, FACPM
Assistant Professor of Clinical Podiatry, UC Health
Cincinnati, OH
Peter A. Crisologo has no relevant financial relationship to disclose

Marvin Eng, MD
Director of Research for the Center of Structural Heart Disease, Henry Ford Hospital
Detroit, MI
Marvin Eng has disclosed the following relevant financial relationships:  Edwards Lifesciences-Proctor, Speaker Bureau; Medtronic-Consultant, Proctor

Dmitriy N. Feldman, MD, FACC, FSCAI, FSVM
Associate Professor of Medicine, New York Presbyterian Hospital/Weill Cornell Medical College
New York, NY
Dmitriy Feldman has no relevant financial relationship to disclose

Lawrence A. Garcia, MD
Chief, Section Interventional Cardiology and Vascular Interventions, Steward St. Elizabeth’s Medical Center
Boston, MA
Lawrence Garcia has disclosed the following relevant financial relationships: Abbott, BSC, Covidien/Medtronic- Consultant, Research Grant; Philips, Syntervention, Arsenal-Consultant

Santiago Garcia, MD
Director, Adult Congenital Structural Program, Minneapolis Heart Institute Foundation
Minneapolis, MN
Santiago Garcia has disclosed the following relevant financial relationships:  Abbott Vascular- Consultant, Speaker Bureau; Edwards Lifesciences- Consultant, Speaker Bureau, Proctor

Allison Hall, MD
Interventional Cardiologist, Clinical Assistant Professor of Medicine, Eastern Health, Memorial University of Newfoundland
Newfoundland, Canada
Allison Hall has no relevant financial relationship to disclose

Kelly Han, MD
Pediatric Cardiologist, The Children’s Heart Clinic, Minneapolis Heart Institute
Minneapolis, MN
Kelly Han has no relevant financial relationship to disclose

Karem C. Harth, MD, MHS, RPVI
Assistant Professor of Surgery, Medical Director HHVI Vascular Laboratories, University Hospitals Cleveland Medical Center
Cleveland, OH
Karem Harth has no relevant financial relationship to disclose

Timothy D. Henry, MD
Medical Director, The Lindner Center for Research and Education, The Christ Hospital
Cincinnati, OH
Timothy Henry has no relevant financial relationship to disclose

James Hermiller, MD, FACC, FSCAI
Director Interventional Cardiology Fellowship and Structural Heart Intervention, St Vincent Heart Center, Ascension Medical Group
Indianapolis, IN
James Hermiller has disclosed the following relevant financial relationships:  Abbott Vascular, Edwards Lifesciences, Medtronic, Biotronik-Consultant

Joseph A. Hill, MD, PhD
Professor and Chief of Cardiology, UT Southwestern Medical Center
Dallas, TX
Joseph Hill has no relevant financial relationship to disclose

Srinivas Iyengar, MD
Structural Heart Director, Boulder Community Health
Boulder, CO
Srinivas Iyengar has no relevant financial relationship to disclose

Eric Jaakola, DPM
Podiatrist, Rose Medical Center
Denver, CO
Eric Jaakola has no relevant financial relationship to disclose

Matthew J. Johnson, DPM
Assistant Professor, Department of Orthopaedic Surgery, University of Texas Southwestern Medical Center
Dallas, TX
Matthew Johnson has no relevant financial relationship to disclose

Damir Jozic, DPM
Chief, Podiatric Surgery, New Mexico VA Healthcare System
Albuquerque, NM
Matthew Johnson has no relevant financial relationship to disclose

Navin K. Kapur, MD
Executive Director, The CardioVascular Center for Research and Innovation (CVCRI); Director, Acute Mechanical Circulatory Support Program; Director, Interventional Research Laboratories; Director of Cardiac Biology Research Center, Molecular Cardiology Research Institute (MCRI); Associate Professor, Tufts University School of Medicine, Tufts Medical Center
Boston, MA
Navin Kapur has disclosed the following relevant financial relationships: Abbott Inc., Abiomed, Boston Scientific, Cardiac Assist, Maquet, Medtronic-Consultant, Speaker Bureau; Precardia-Consultant

Kate Kearney, MD
Interventional Cardiologist, University of Washington Medical Center
Seattle, WA
Kate Kearney has disclosed the following relevant financial relationships:  Boston Scientific, Teleflex-Consultant

Jaikirshan Khatri, MD
Director of Complex Coronary Intervention, Cleveland Clinic
Cleveland, OH
Jaikirshan Khatri has disclosed the following relevant financial relationships: Abbott-Proctor, Course Faculty; Asahi-Research funding, Speaker Bureau; Boston Scientific-Consultant

Chad Kliger, MD
Director, Valve and Structural Heart Center, Lenox Hill Heart and Lung – Northwell Health
New York, NY
Chad Kliger has no relevant financial relationship to disclose

Daniel Kolansky, MD
Associate Chief for Clinical Affairs, Cardiovascular Medicine; Director, Cardiac Care Unit; Professor of Medicine, Hospital of the University of Pennsylvania
Philadelphia, PA
Daniel Kolansky has no relevant financial relationship to disclose

Ethan Korngold, MD
Division Chair, Interventional Cardiology and Structural Heart, Providence Heart Institute
Providence, RI
Ethan Korngold has disclosed the following relevant financial relationships:  Abbott Vascular-Consultant, Speaker Bureau; Boston Scientific, Edwards Lifesciences, Medtronic-Consultant

Azeem Latib, MD
Section Head of interventional Cardiology, Montefiore Medical Center
New York, NY
Azeem Latib has disclosed the following relevant financial relationships:  Abbott Vascular, Edwards Lifesciences, Medtronic, NeoChord, Philips-Consultant

Jun Li, MD, PhD
Cardiology-Interventional Cardiology, Cardiology-Vascular Medicine, University Hospitals Parma Medical Center
Parma, OH
Jun Li has disclosed the following relevant financial relationships:  Abbott Vascular, Abiomed, Medtronic, Terumo Medical-Consultant

William L. Lombardi, MD
Director, Complex Coronary Artery Disease Therapies, University of Washington Medical Center
Seattle, WA
William Lombardi has disclosed the following relevant financial relationships:  Abbott Vascular, Boston Scientific-Consultant, Proctor; Asahi Intecc, Teleflex-Consultant

Robert Lookstein, MD
Professor of Radiology and Surgery, Ichan School of Medicine, The Mount Sinai Hospital
New York, NY
Robert Lookstein has disclosed the following relevant financial relationships: Abbott Vascular-Spouse-Consultant; Boston Scientific, Medtronic-Consultant

Rose Lumare, DPM
Chief, Podiatric Surgery, VA North Texas Health Care System
Dallas, TX
Rose Lumare has no relevant financial relationship to disclose

Doff McElhinney, MD
Professor of Cardiothoracic Surgery and of Pediatrics, Stanford Health Care
Palo Alto, CA
Doff McElhinney has disclosed the following relevant financial relationship: Medtronic-Consultant

Roxana Mehran, MD
Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes; Director of Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai
New York, NY
Roxana Mehran has disclosed the following relevant financial relationships:  Abbott Laboratories, Abiomed, Boston Scientific, Idorsia Pharmaceuticals, Phillips/volcano/Spectranetics, Regeneron Pharmaceuticals, Roivant Sciences, Sanofi, Siemens Medical Solutions, The Medicines Company-Consultant; ACC-Associate Editor; Astra Zeneca, Bayer, Beth Israel Deaconess, CERC, Chiesi, Janssen Pharmaceuticals, Concept Medical, Medscape/WebMD, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich-Research Support; Bristol Myers Squibb-Advisory Board; Medtelligence (Janssen Scientific Affairs)-Advisory and Speaker; All Research Support listed above is “paid to the institution”

Peter P. Monteleone, MD
Assistant Professor, UT Austin Dell School of Medicine
Austin, TX
Peter Monteleone has disclosed the following relevant financial relationships:  Medtronic, Biotronik - Consultant

Gareth Morgan, MD, BaO, BCh, MRCPCH
Director of Congenital Interventional Cardiology; Assoc Professor, University of Colorado
Aurora, CO
Gareth Morgan has no relevant financial relationship to disclose

Brian Morray, MD
Assistant Professor, Seattle Children’s Hospital
Seattle, WA
Brian Morray has disclosed the following relevant financial relationships:  Medtronic-Consultant

Srihari S. Naidu, MD, FACC, FSCAI
Director, Cardiac Catheterization Laboratory and Director, Hypertrophic Cardiomyopathy Center, Westchester Medical Center
Valhalla, NY
Srihari Naidu has no relevant financial relationship to disclose

Sahil A. Parikh, MD
Associate Professor of Medicine, NY Presbyterian/Columbia University Medical Center
New York, NY
Sahil Parikh has no relevant financial relationships to disclose

Manesh Patel, MD
Chief, Division of Cardiology, Director Heart Center, Duke University
Durham, NC
Manesh Patel has disclosed the following relevant financial relationships:  AstraZeneca, Bayer Healthcare LLC, Jansen-Consultant

Mitul P. Patel, MD
Interventional Cardiology, UC San Diego Health System
San Diego, CA
Mitul Patel has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, Cardiovascular Systems, Chiesi, Medtronic; Terumo-Consultant

Ashish Pershad, MD
Associate Professor of Medicine, Banner University Medical Center and University of Arizona College of Medicine Phoenix
Phoenix, AZ
Ashish Pershad has no relevant financial relationship to disclose

Bala Ramanan, MBBS, MS, FACS
Assistant Professor of Surgery, University of Texas Southwestern Medical Center
Dallas, TX
Bala Ramanan has no relevant financial relationship to disclose

Sunil Rao, MD
Professor of Medicine, Duke University Medical Center
Durham, NC
Sunil Rao has no relevant financial relationship to disclose

Andrew Rassi, MD
Medical Director, Cardiac Catheterization Laboratory, Kaiser Permanente - San Francisco Medical Center
San Francisco, CA
Andrew Rassi has no relevant financial relationship to disclose

Rose Resendez, DPM
Podiatry Specialist, Podiatric Medical Partners of Texas
Irving, TX
Rose Resendez has disclosed the following relevant financial relationships:  Organogenesis-Consultant

Robert F. Riley, MD, MS
Research and Medical Director, Complex Coronary Therapeutic Program, The Christ Hospital Health System
Cincinnati, OH
Robert Riley has disclosed the following relevant financial relationships:  Medtronic, Boston Scientific, Asah Intecc-Consultant, Speaker Bureau

Sheila Sahni, MD
Director of Women's Heart Program, Sahni Heart Center, Hackensack Meridian Health Medical Group
Hackensack, NJ
Sheila Sahni has no relevant financial relationship to disclose

Yader Sandoval, MD
Assistant Professor of Medicine, Interventional Cardiologist, Mayo Clinic
La Crosse, WI
Yader Sandoval has no relevant financial relationship to disclose

Jacqueline Saw, MD, FRCPC, FACC, FAHA, FSCAI, FSCCT
Clinical Professor, Vancouver General Hospital
Vancouver, BC, Canada
Jacqueline Saw has disclosed the following relevant financial relationships:  Abbott Vascular-Consultant, Proctor, Speaker; Boston Scientific-Consultant, Proctor; CIHR: Heart and Stroke Foundation-Research Grant; WL Gore, Baylis-Consultant

Arnold Seto, MD
Chief of Cardiology, Long Beach VA Medical Center
Long Beach, CA
Arnold Seto has disclosed the following relevant financial relationships: Acist Medical, Philips-Research Grant; Boston Scientific; Opsens-Speaker Bureau

Binita Shah, MD, MS
Associate Director of the Cath Lab, VA NY Harbor Healthcare System; Associate Director of Cath Lab Research, NYU Langone Health
New York, NY
Binita Shah has disclosed the following relevant financial relationships:  Phillips Volcano Spectranetics, Radux Technology-Advisory Board; Terumo Medical-Consultant

Rahul Sharma, MD
Director of Structural Interventions
Stanford Health Care
Rahul Sharma has disclosed the following relevant financial relationships: Abbott, Boston Scientific, Edwards Lifescience, Siemens Healthineers-Consultant

Mehdi Shishehbor, DO, MPH, PhD
Director, Cardiovascular Interventional Center, University Hospitals Cleveland Medical Center
Cleveland, OH
Mehdi Shishehbor has no relevant financial relationship to disclose

Evan Shlofmitz, DO
Interventional Cardiology Fellow, MedStar Washington Hospital Center
Washington, DC
Evan Shlofmitz has disclosed the following relevant financial relationships:  Abbott Vascular, Opsens-Consultant

Gagan Singh, MD, FACC, FSCAI
Associate Professor of Medicine, UC Davis Medical Center
Sacramento, CA
Gagan Singh has disclosed the following relevant financial relationships:  Abbott Vascular-Consultant, Speaker Bureau

Paul Sorajja, MD
Director, Center for Valve and Structural Heart Diseases, Minneapolis Heart Institute at Abbott Northwestern Hospital
Minneapolis, MN
Paul Sorajja has disclosed the following relevant financial relationships:  Abbott Vascular-Consultant, Research Grant, Speaker Bureau; Admedus, Teleflex; WL Gore-Consultant; Boston Scientific, Edwards Lifesciences; Medtronic-Consultant, Research Grant

Peter Soukas, MD
Director, Vascular Medicine & Interventional PV Lab, Brown Medical School
Providence, RI
Peter Soukas has no relevant financial relationship to disclose

Molly Szerlip MD, FSCAI, FACC
Medical Director of Percutaneous Valve Program, Program Director, Structural Heart Fellowship,
Baylor Scott and White: The Heart Hospital Plano
Plano, TX
Molly Szerlip has disclosed the following relevant financial relationships:  Boston Scientific-Speaker Bureau; Edwards Lifesciences-Speaker Bureau, Consultant

Vinod Thourani, MD
Marcus Chief of Cardiovascular Surgery, Marcus Valve Center, Piedmont Heart Institute and Piedmont Healthcare
Atlanta, GA
Vinod Thourani has disclosed the following relevant financial relationships:  Boston Scientific, Abbott Vascular, Edwards Lifesciences, Jenavalve, W. L. Gore Associates-Consultant

David H. Truong, DPM, MS, DABPM
Staff Physician, VA North Texas Health Care System
Dallas, TX
David H. Truong has no relevant financial relationship to disclose

Shirling Tsai, MD
Assistant Professor, Department of Surgery, UT Southwestern Medical Center
Dallas, TX
Shirling Tsai has no relevant financial relationship to disclose

Poonam Velagapudi, MD, MS
Structural Interventional Cardiologist, Assistant Professor of Medicine, University of Nebraska Medical Center
Omaha, NE
Poonam Velagapudi has no relevant financial relationship to disclose

Christopher J. White, MD
System Chairman of Cardiology, Ochsner Health System
Jefferson, LA
Christopher White has no relevant financial relationship to disclose

Jason Wollmuth, MD
Interventional Cardiologist, Providence Heart and Vascular Institute
Providence, RI
Jason Wollmuth has disclosed the following relevant financial relationships:  Abbott St. Jude Medical, Abiomed, Boston Scientific-Consultant, Speaker Bureau; Ashai Intecc, Philips-Consultant

Steven Yakubov, MD, FACC
Medical Director, OhioHealth Research Institute
Columbus, OH
Steven Yakubov has disclosed the following relevant financial relationships:  Boston Scientific-Advisory Board, Consultant; Medtronic-Speaker Bureau

Firas Zahr, MD
Director of interventional Cardiology, Oregon Health and Science University
Portland, OR
Firas Zahr has disclosed the following relevant financial relationships:  Edwards Lifesciences, Medtronic-Research Grant

Alan Zajarias, MD
Co-Director Center of Valve Disease, Washington University School of Medicine
St. Louis, MO
Alan Zajarias has disclosed the following relevant financial relationships:  Admedus, Boston Scientific, Edwards Lifesciences-Consultant

Thomas Zeller, MD
Head Department Angiology, University Heart-Center Freiburg
Bad Krozingen, Germany
Thomas Zeller has disclosed the following relevant financial relationships:  Abbott Vascular, Bayer, Boston Scientific, Cook, GORE, Inact, Medtronic, QT Medical, Shockwave, Veryan, Vesper-Consultant

Evan Zhan, MD
Director, Congenital Heart Program, Cedars-Sinai Medical Center
Los Angeles, CA
Evan Zhan has no relevant financial relationships to disclose

Planner Disclosures
No member of CMEsolutions or Cardiovascular Innovations Foundation has any relevant financial relationships to disclose in regards to this activity.

Kelly Desatnik
Program Director, Cardiovascular Innovations Foundation
Denver, CO
Nothing to Disclose

Joel Brill, MD, FACP
Professor of Medicine, University of Arizona and Midwestern University
Scottsdale, AZ
Nothing to Disclose

Christopher King, BS
Managing Partner, CMEsolutions
Camden, ME
Nothing to Disclose

Off-label Use

This activitymay contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for this live educational activity will be provided by the following:
Abbott
BD
Cook Medical
Edwards Lifesciences
GE Healthcare
Medtronic
Terumo

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org .


 complete evaluation/credit request